FIELD: medicine.
SUBSTANCE: invention relates to the field of genetic engineering. Claimed is an isolated molecule of nucleic acid for the therapy of hens or for the support, stimulation or enhancement of their immune response, selected from a number of molecules, which code lambda-interferon (INF-λ)) of hens, represented in SEQ ID NO: 1 or 3, or molecules, which represent a nucleic sequence, which codes an amino acid sequence, given in SEQ ID NO: 2 or 4, or a sequence of nucleic acid, capable of hybridising with SEQ ID No: 1 or 3 in high-stringency conditions, an isolated polypeptide, a therapeutic method and application for the therapy of hens are also claimed.
EFFECT: invention makes it possible to realise therapy and diagnostics of hens.
13 cl, 4 tbl, 15 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INTERFERON-LIKE PROTEIN ZCYTO21 | 2001 |
|
RU2292394C2 |
| RECOMBINANT VACCINE AGAINST AVIAN FLU AND APPLICATION THEREOF | 2009 |
|
RU2559527C2 |
| ANTIBODIES RAISED AGAINST α-INTERFERON | 2002 |
|
RU2314317C2 |
| PROTEIN SHOWING INTERFERON-LIKE ANTIVIRAL AND ANTIPROLIFERATIVE BIOLOGICAL ACTIVITIES (VERSIONS), PROTEIN STRUCTURE, CODING POLYNUCLEOTIDE (VERSIONS), EXPRESSION VECTOR, HOST CELL, COMPOSITION AND USE OF PROTEIN AS ANTIVIRAL, ANTIPROLIFERATIVE, ANTICANCER OR IMMUNOMODULATORY AGENT AND METHOD OF TREATING CONDITION SENSITIVE TO INTERFERON-THERAPY, CANCER OR VIRAL DISEASE | 2007 |
|
RU2469091C2 |
| CLOSTRIDIAL TOXIN NetB | 2008 |
|
RU2474587C2 |
| POLYPEPTIDE WITH ANTIVIRAL ACTIVITY, ITS PRODUCTION AND USE | 2004 |
|
RU2372356C2 |
| HOMOGENOUS PREPARATIONS OF IL-28 AND IL-29 | 2004 |
|
RU2518324C2 |
| RECOMBINANT BLUETONGUE VACCINE | 2007 |
|
RU2446823C2 |
| H1N1 INFLUENZA VIRUS ANTIGENS WITH WIDE SPECTRUM OF ACTIVITY, OPTIMIZED USING COMPUTER TOOLS | 2012 |
|
RU2612900C2 |
| COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR H3N2 VIRUSES | 2013 |
|
RU2653756C2 |
